45.6 USD
-1.3 (-2.77%)
45.6 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 191 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on COLL. These ratings would make COLL suitable for value investing!
1. Profitability
1.1 Basic Checks
- COLL had positive earnings in the past year.
- In the past year COLL had a positive cash flow from operations.
- Of the past 5 years COLL 4 years were profitable.
- Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 3.64%, COLL belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 21.27%, COLL belongs to the top of the industry, outperforming 91.15% of the companies in the same industry.
- COLL has a Return On Invested Capital of 9.10%. This is amongst the best in the industry. COLL outperforms 88.02% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for COLL is in line with the industry average of 12.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROIC | 9.1% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
- With an excellent Profit Margin value of 7.72%, COLL belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
- In the last couple of years the Profit Margin of COLL has declined.
- COLL has a better Operating Margin (20.74%) than 88.54% of its industry peers.
- In the last couple of years the Operating Margin of COLL has grown nicely.
- COLL has a better Gross Margin (57.22%) than 68.75% of its industry peers.
- In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COLL is still creating some value.
- Compared to 1 year ago, COLL has less shares outstanding
- The number of shares outstanding for COLL has been reduced compared to 5 years ago.
- Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.46, we must say that COLL is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of 1.46, COLL perfoms like the industry average, outperforming 55.21% of the companies in the same industry.
- COLL has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as COLL would need 2.79 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.79, COLL belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.
- COLL has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
- COLL's Debt to Equity ratio of 2.71 is on the low side compared to the rest of the industry. COLL is outperformed by 80.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 1.46 |
ROIC/WACC0.98
WACC9.27%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that COLL should not have too much problems paying its short term obligations.
- COLL has a worse Current ratio (1.36) than 74.48% of its industry peers.
- A Quick Ratio of 1.27 indicates that COLL should not have too much problems paying its short term obligations.
- COLL's Quick ratio of 1.27 is on the low side compared to the rest of the industry. COLL is outperformed by 70.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
- COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.73%, which is quite impressive.
- Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
- The Revenue has grown by 26.34% in the past year. This is a very strong growth!
- Measured over the past years, COLL shows a quite strong growth in Revenue. The Revenue has been growing by 16.31% on average per year.
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
3.2 Future
- Based on estimates for the next years, COLL will show a decrease in Earnings Per Share. The EPS will decrease by -1.58% on average per year.
- COLL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.62% yearly.
EPS Next Y18.1%
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
EPS Next 5Y-1.58%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y3.62%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 6.34, the valuation of COLL can be described as very cheap.
- COLL's Price/Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 94.79% of the companies in the same industry.
- When comparing the Price/Earnings ratio of COLL to the average of the S&P500 Index (27.38), we can say COLL is valued rather cheaply.
- A Price/Forward Earnings ratio of 5.60 indicates a rather cheap valuation of COLL.
- Based on the Price/Forward Earnings ratio, COLL is valued cheaper than 94.27% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. COLL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.34 | ||
| Fwd PE | 5.6 |
4.2 Price Multiples
- 98.44% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
- COLL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. COLL is cheaper than 96.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.98 | ||
| EV/EBITDA | 4.77 |
4.3 Compensation for Growth
- COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of COLL may justify a higher PE ratio.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
5. Dividend
5.1 Amount
- COLL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
45.6
-1.3 (-2.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners120.33%
Inst Owner Change1.05%
Ins Owners1.42%
Ins Owner Change-0.82%
Market Cap1.44B
Revenue(TTM)757.07M
Net Income(TTM)58.44M
Analysts81.67
Price Target54.23 (18.93%)
Short Float %17.23%
Short Ratio10.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.9%
Min EPS beat(2)1.88%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.15%
Min EPS beat(4)1.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)-15.06%
EPS beat(16)10
Avg EPS beat(16)-21.97%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)1.9%
Max Revenue beat(2)8.53%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)8.53%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-3.75%
PT rev (1m)13.6%
PT rev (3m)19.21%
EPS NQ rev (1m)-3.66%
EPS NQ rev (3m)3.93%
EPS NY rev (1m)-0.9%
EPS NY rev (3m)-9.58%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)3.24%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)3.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.34 | ||
| Fwd PE | 5.6 | ||
| P/S | 1.9 | ||
| P/FCF | 4.98 | ||
| P/OCF | 4.95 | ||
| P/B | 5.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.77 |
EPS(TTM)7.19
EY15.77%
EPS(NY)8.14
Fwd EY17.85%
FCF(TTM)9.15
FCFY20.07%
OCF(TTM)9.2
OCFY20.18%
SpS23.95
BVpS8.69
TBVpS-18.86
PEG (NY)0.35
PEG (5Y)N/A
Graham Number37.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROCE | 13.6% | ||
| ROIC | 9.1% | ||
| ROICexc | 12.09% | ||
| ROICexgc | N/A | ||
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% | ||
| FCFM | 38.21% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score7
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.94 | ||
| Cap/Depr | 0.72% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 2.17 | ||
| Cash Conversion | 75.92% | ||
| Profit Quality | 495.01% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.46 |
F-Score7
WACC9.27%
ROIC/WACC0.98
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
EPS Next Y18.1%
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
EPS Next 5Y-1.58%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y3.62%
EBIT growth 1Y-18.86%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year154.57%
EBIT Next 3Y23.61%
EBIT Next 5Y18.85%
FCF growth 1Y8.55%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y8.67%
OCF growth 3Y25.54%
OCF growth 5Y49.12%
COLLEGIUM PHARMACEUTICAL INC / COLL FAQ
What is the ChartMill fundamental rating of COLLEGIUM PHARMACEUTICAL INC (COLL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to COLL.
What is the valuation status for COLL stock?
ChartMill assigns a valuation rating of 9 / 10 to COLLEGIUM PHARMACEUTICAL INC (COLL). This can be considered as Undervalued.
What is the profitability of COLL stock?
COLLEGIUM PHARMACEUTICAL INC (COLL) has a profitability rating of 8 / 10.
Can you provide the financial health for COLL stock?
The financial health rating of COLLEGIUM PHARMACEUTICAL INC (COLL) is 5 / 10.